Human VEGF 384 Tissue Culture Kit

Related Publications	Journal	Year

Placental growth factor and soluble c-kit receptor dynamics characterize the cytokine signature of imatinib in prostate cancer and bone metastases. Mathew, P., Wen, S., Morita, S., Thall, P.F.	J Interferon Cytokine Res.	2011
Androgen stimulates endothelial cell proliferation via an androgen receptor/VEGF/cyclin A-mediated mechanism. Cai, J., Hong, Y., Weng, C., Tan, C., Imperato-McGinley, J., Zhu, Y.S.	Am J Physiol Heart Circ Physiol.	2011
Blood protein concentrations in the first two postnatal weeks associated with early postnatal blood gas derangements among infants born before the 28th week of gestation. The ELGAN Study. Leviton, A., Allred, E.N., Kuban, K.C., Dammann, O., Fichorova, R.N., O'Shea, T.M., Paneth, N.; for the ELGAN Study Co-Investigators.	Cytokine.	2011
Persistence after birth of systemic inflammation associated with umbilical cord inflammation. Leviton, A., Hecht, J.L., Allred, E.N., Yamamoto, H., Fichorova, R.N., Dammann, O.; for the ELGAN Study Investigators.	J Reprod Immunol.	2011
Cluster Analysis of Placental Inflammatory Proteins Can Distinguish Preeclampsia from Preterm Labor and Premature Membrane Rupture in Singleton Deliveries Less Than 28 Weeks of Gestation. Faupel-Badger, J.M., Fichorova, R.N., Allred, E.N., Hecht, J.L., Dammann, O., Leviton, A., McElrath, T.F.	Am J Reprod Immunol.	2011
A phase 2 study of pegylated interferon α-2b (PEG-Intron®) in children with diffuse intrinsic pontine glioma. Warren, K., Bent, R., Wolters, P.L., Prager, A., Hanson, R., Packer, R., Shih, J., Camphausen, K.	Cancer.	2011
Systemic responses of preterm newborns with presumed or documented bacteremia. Leviton, A., O'Shea, M.T., Bednarek, F.J., Allred, E.N., Fichorova, R.N., Dammann, O.; for the ELGAN Study Investigators.	Acta Paediatr.	2011
The relationship between neonatal blood protein profiles and placenta histologic characteristics in extremely low gestation age newborns. Hecht, J.L., Fichorova, R.N., Tang, V.F., Allred, E.N., McElrath, T.F., Leviton, A; for the ELGAN study investigators.	Pediatr Res.	2010
Inflammation-related proteins in the blood of extremely low gestational age newborns. The contribution of inflammation to the appearance of developmental regulation. Leviton, A., Fichorova, R., Yamamoto, Y., Allred, E.N., Dammann, O., Hecht, J., Kuban, K., McElrath, T., O'Shea, T.M., Paneth, N.	Cytokine	2010
Phase I and Pharmacokinetic Study of CT-322 (BMS-844203), a Targeted Adnectin Inhibitor of VEGFR-2 Based on a Domain of Human Fibronectin. Tolcher, A.W., Sweeney, CJ., Papadopoulos, K., Patnaik, A., Chiorean, E.G., Mita, A.C., Sankhala, K., Furfine, E., Gokemeijer, J., Iacono, L., Eaton, C., Silver, B.A., Mita, M.	Clin Cancer Res.	2010
The 4q12 Amplicon in Malignant Peripheral Nerve Sheath Tumors: Consequences on Gene Expression and Implications for Sunitinib Treatment. Zietsch, J., Ziegenhagen, N., Heppner, F.L., Reuss, D., von Deimling, A., Holtkamp, N.	PLoS One	2010
Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study. Willett, C.G., Duda, D.G., di Tomaso, E., Boucher, Y., Ancukiewicz, M., Sahani, D.V., Lahdenranta, J., Chung, D.C., Fischman, A.J., Lauwers, G.Y., Shellito, P., Czito, B.G., Wong, T.Z., Paulson, E., Poleski, M., Vujaskovic, Z., Bentley, R., Chen, H.X., Clark, J.W., Jain, R.K.	Journal of Clinical Oncology.	2009
Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study. Zhu, A.X., Sahani, D.V., Duda, D.G., di Tomaso, E., Ancukiewicz, M., Catalano, O.A., Sindhwani, V., Blaszkowsky, L.S. Yoon, S.S., Lahdenranta, J., Bhargava, P., Meyerhardt, J. Clark, J.W., Kwak, E.L., Hezel, A.F., Miksad, R., Abrams, T.A., Enzinger, P.C., Fuchs, C.S., Ryan, D.P., Jain, R.K.	Journal of Clinical Oncology.	2009
Simultaneous Detection of Eight Analytes in Human Serum by Two Commercially Available Platforms for Multiplex Cytokine Analysis. Toedter, G., Hayden, K., Wagner, C., Brodmerkel, C.	Clin Vaccine Immunol.	2008
Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors. Giaccone, G., Rajan, A., Berman, A., Kelly, R.J., Szabo, E., Lopez-Chavez, A., Trepel, J., Lee, M.J., Cao, L., Espinoza-Delgado, I., Spittler, J., Loehrer, P.J. Sr.	J Clin Oncol.	2011
Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomas. Kummar, S., Gutierrez, M.E., Chen, A., Turkbey, I.B., Allen, D., Horneffer, Y.R., Juwara, L., Cao, L., Yu, Y., Kim, Y.S., Trepel, J., Chen, H., Choyke, P., Melillo, G., Murgo, A.J., Collins, J., Doroshow, J.H.	Eur J Cancer.	2011
Biomarkers as Predictors of Response to Treatment with Motesanib in Patients with Progressive Advanced Thyroid Cancer. Bass, M.B., Sherman, S.I., Schlumberger, M.J., Davis, M.T., Kivman, L., Khoo, H.M., Notari, K.H., Peach, M., Hei, Y.J., Patterson, S.D.	J Clin Endocrinol Metab.	2010
Elevated levels of plasma angiogenic factors are associated with human lymphatic filarial infections. Bennuru, S., Maldarelli, G., Kumaraswami, V., Klion, A.D., Nutman, T.B.	Am J Trop Med Hyg.	2010
Phase 1 study of the investigational, oral angiogenesis inhibitor motesanib in Japanese patients with advanced solid tumors. Fujisaka, Y., Yamada, Y., Yamamoto, N., Shimizu, T., Fujiwara, Y., Yamada, K., Tamura, T., Watanabe, H., Sun, Y.N., Bass, M.B., Seki, M.	Cancer Chemother Pharmacol.	2010
Serum correlates of the placebo effect in irritable bowel syndrome. Kokkotou, E., Conboy, L.A., Ziogas, D.C., Quilty, M.T., Kelley, J.M., Davis, R.B., Lembo, A.J., Kaptchuk, T.J.	Neurogastroenterol Motil.	2010
Phase II Study of Neoadjuvant Bevacizumab and Radiotherapy for Resectable Soft Tissue Sarcomas. Yoon, S.S., Duda, D.G., Karl, D.L., Kim, T.M., Kambadakone, A.R., Chen, Y.L., Rothrock, C., Rosenberg, A.E., Nielsen, G.P., Kirsch, D.G., Choy, E., Harmon, D.C., Hornicek, F.J., Dreyfuss, J., Ancukiewicz, M., Sahani, D.V., Park, P.J., Jain, R.K., Delaney, T.F.	Int J Radiat Oncol Biol Phys.	2010
Combination Targeted Therapy With Sorafenib and Bevacizumab Results in Enhanced Toxicity and Antitumor Activity. Azad, N.S., Posadas, E.M., Kwitkowski, V.E., Steinberg, S.M., Jain, L., Annunziata, C.M., Minasian, L., Sarosy, G., Kotz, H.L., Premkumar, A., Cao, L., McNally, D., Chow, C., Chen, H.X., Wright, J.J., Figg, W.D., Kohn, E.C.	J Clin Oncol.	2008
AZD2171, a Pan-VEGF receptor tyrosine Kinase Inhibitor, Normalizes tumor vasculature and alleviates edema in glioblastoma patients. Batchelor, T., Sorensen, A.G., di Tomaso, E., Zhang, W.T., Duda, D.G., Cohen, K.S., Kozak, K.R., Cahill, D.P., Chen, P.J., Zhu, M., Ancukiewicz, M., Mrugala, M.M., Plotkin, S., Drappatz, J., Louis, D.N., Ivy, P., Scadden, D.T., Benner, T., Loeffler, J.S., Wen, P.Y., Jain, R.K.	Cancer Cell.	2007
Safety, pharmacokinetics, and efficacy of AMG 706, an oral multikinase inhibitor, in patients with advanced solid tumors. Rosen, L., Kurzrock, R., Mulay, M., Van Vugt, A., Purdom, M., Ng, C., Silverman, J., Koutsoukos, A., Sun, Y.N., Bass, M.B., Xu, R.Y., Polverino, A., Wiezorek, J.S., Chang, D.D., Benjamin, R., Herbst, R.S.	Clin Oncol.	2007
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. Willett, C.G., Boucher, Y., Duda, D.G., di Tomaso, E., Munn, L.L., Tong, R.T., Kozin, S.V., Petit, L., Jain, R.K., Chung, D.C., Sahani, D.V., Kalva, S.P., Cohen, K.S., Scadden, D.T., Fischman, A.J., Clark, J.W., Ryan, D.P., Zhu, A.X., Blaszkowsky, L.S., Shellito, P.C., Mino-Kenudson, M., Lauwers, G.Y.	J Clin Oncology.	2005
Maternal Microbe-Specific Modulation of Inflammatory Response in Extremely Low-Gestational-Age Newborns Fichorova, R.N., Onderdonk, A.B., Yamamoto, H., Delaney, M.L., DuBois, A.M., Allred, E., Levition, A; for the ELGAN Study Investigators.	mBio	2011
Phase 1 study of AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, in combination with chemotherapy in adults with advanced solid tumors. Mita, A.C., Takimoto, C.H., Mita, M., Tolcher, A., Sankhala, K., Sarantopoulos, J., Valdivieso, M., Wood, L., Rasmussen, E., Sun, Y.N., Zhong, Z.D., Bass, M.B., Le, N., LoRusso, P.	Clinical Cancer Research	2010
Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma. Horowitz, N.S., Penson, R.T., Duda, D.G., di Tomaso, E., Boucher, Y., Ancukiewicz, M., Cohen, K.S., Berlin, S., Krasner, C.N., Moses, M.A., Jain, R.K.	Clin Ovarian Cancer Other Gynecol Malig.	2011
Relationship Between Neonatal Blood Protein Concentrations and Placenta Histologic Characteristics in Extremely Low GA Newborns. Hecht, J.L., Fichorova, R.N., Tang, V.F., Allred, E.N., McElrath, T.F., Leviton, A; Elgan Study Investigators.	Pediatr Res.	2011
Evaluation of KRAS mutations, angiogenic biomarkers and DCE-MRI in patients with advanced non-small cell lung cancer receiving sorafenib. Kelly, R.J., Rajan, A., Force, J., Keen, C., Cao, L., Yu, Y., Choyke, P.L., Turkbey, B., Raffeld, M., Xi, L., Steinberg, S.M., Wright, J.J., Lopez-Chavez, A., Kummar, S., Guttierrez, M., Giaccone, G.	Clin Cancer Res.	2011
Early postnatal blood concentrations of inflammation-related proteins and microcephaly two years later in infants born before the 28th post-menstrual week. Leviton, A., Kuban, K.C., Allred, E.N., Fichorova, R.N., O'Shea, T.M., Paneth, N.; for the ELGAN Study Investigators.	Early Hum Dev.	2011
The Relationship between Early Concentrations of 25 Blood Proteins and Cerebral White Matter Injury in Preterm Newborns: The ELGAN Study. Leviton, A., Kuban, K., O'Shea, T.M., Paneth, N., Fichorova, R., Allred, E.N., Dammann, O.	J Pediatr.	2011
Placental Growth Factor and Soluble c-Kit Receptor Dynamics Characterize the Cytokine Signature of Imatinib in Prostate Cancer and Bone Metastases. Mathew, P., Wen, S., Morita, S., Thall, P.F.	J Interferon Cytokine Res.	2011
Blood protein profiles of infants born before 28th week differ by pregnancy complication. McElrath, T.F., Fichorova, R.N., Allred, E.N., Hecht, J.L., Ismail, M.A., Yuan, H., Leviton, A; ELGAN Study Investigators.	Am J Obstet Gynecol.	2011
Exploratory analysis of early toxicity of sunitinib in advanced hepatocellular carcinoma patients: kinetics and potential biomarker value. Zhu, A.X., Duda, D.G., Ancukiewicz, M., di Tomaso, E., Clark, J.W., Miksad, R., Fuchs, C.S., Ryan, D.P., Jain, R.K.	Clin Cancer Res.	2011
Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma. Batchelor, T.T., Duda, D.G., di Tomaso, E., Ancukiewicz, M., Plotkin, S.R., Gerstner, E., Eichler, A.F., Drappatz, J., Hochberg, F.H., Benner, T., Louis, D.N., Cohen, K.S., Chea, H., Exarhopoulos, A., Loeffler, J.S., Moses, M.A., Ivy, P., Sorensen, A.G., Wen, P.Y., Jain, R.K.	J Clin Oncol.	2010
Fetal-placental inflammation, but not adrenal activation, is associated with extreme preterm delivery. Trivedi S, Joachim M, McElrath T, Kliman HJ, Allred EN, Fichorova RN, Onderdonk A, Heitor F, Chaychi L, Leviton A, Majzoub JA; ELGAN study investigators.	Am J Obstet Gynecol.	2011
The characterization of fibrocyte-like cells: A novel fibroblastic cell of the placenta. Riddell MR, Winkler-Lowen B, Chakrabarti S, Dunk C, Davidge ST, Guilbert LJ.	Placenta.	2012
Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. Bafadhel M, McCormick M, Saha S, McKenna S, Shelley M, Hargadon B, Mistry V, Reid C, Parker D, Dodson P, Jenkins M, Lloyd A, Rugman P, Newbold P, Brightling CE.	Respiration.	2012
Effects of Sorafenib on Intra-Tumoral Interstitial Fluid Pressure and Circulating Biomarkers in Patients with Refractory Sarcomas (NCI Protocol 6948). Raut CP, Boucher Y, Duda DG, Morgan JA, Quek R, Ancukiewicz M, Lahdenranta J, Eder JP, Demetri GD, Jain RK.	PLoS One.	2012
Langerhans cells from human cutaneous squamous cell carcinoma induce strong type 1 immunity. Fujita H, Suárez-Fariñas M, Mitsui H, Gonzalez J, Bluth MJ, Zhang S, Felsen D, Krueger JG, Carucci JA.	J Invest Dermatol.	2012
Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study. Bakker MF, Cavet G, Jacobs JW, Bijlsma JW, Haney DJ, Shen Y, Hesterberg LK, Smith DR, Centola M, van Roon JA, Lafeber FP, Welsing PM.	Ann Rheum Dis.	2012
Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines. Yeung TY, Seeberger KL, Kin T, Adesida A, Jomha N, Shapiro AM, Korbutt GS.	PLoS One	2012
Prostaglandin E2: a putative potency indicator of the immunosuppressive activity of human mesenchymal stem cells. Solchaga, LA, Zale, EA.	Am J Stem Cell	2012
Characterization of a multiplex, 12-biomarker test for rheumatoid arthritis. Eastman PS, Manning WC, Qureshi F, Haney D, Cavet G, Alexander C, Hesterberg LK.	J Pharm Biomed Anal.	2012
A Phase I Study of the Combination of Sorafenib With Temozolomide and Radiation Therapy for the Treatment of Primary and Recurrent High-Grade Gliomas. Den RB, Kamrava M, Sheng Z, Werner-Wasik M, Dougherty E, Marinucchi M, Lawrence YR, Hegarty S, Hyslop T, Andrews DW, Glass J, Friedman DP, Green MR, Camphausen K, Dicker AP.	Int J Radiat Oncol Biol Phys.	2012
Validation of a novel multi-biomarker test to assess rheumatoid arthritis disease activity. Curtis JR, van der Helm-van Mil AH, Knevel R, Huizinga TW, Haney DJ, Shen Y, Ramanujan S, Cavet G, Centola M, Hesterberg LK, Chernoff D, Ford K, Shadick NA, Hamburger M, Fleischmann R, Keystone E, Weinblatt ME.	Arthritis Care Res.	2012
Blood protein concentrations in the first two postnatal weeks that predict bronchopulmonary dysplasia among infants born before the 28th week of gestation. Bose, C., Laughon, M., Allred, E.N., Van Marter, L.J., O'shea, T.M., Ehrenkranz, R.A., Fichorova, R., Leviton, A; for the ELGAN Study Investigators.	Pediatr Res.	2011
Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer. De Boer RH, Kotasek D, White S, Koczwara B, Mainwaring P, Chan A, Melara R, Ye Y, Adewoye AH, Sikorski R, Kaufman PA.	Breast Cancer Res Treat.	2012
Pharmacokinetic and pharmacodynamic analysis of circulating biomarkers of anti-NRP1, a novel anti-angiogenesis agent, in two phase I trials in patients with advanced solid tumors. Xin Y, Li J, Wu J, Kinard R, Weekes CD, Patnaik A, Lorusso PM, Brachmann R, Tong RK, Yan Y, Watts R, Bai S, Hegde PS.	Clin Cancer Res.	2012
Systemic inflammation associated with severe intestinal injury in extremely low gestational age newborns. Martin CR, Bellomy M, Allred EN, Fichorova RN, Leviton A.	Fetal Pediatr Pathol.	2012
Impaired pten expression in human malignant peripheral nerve sheath tumours. Bradtmöller M, Hartmann C, Zietsch J, Jäschke S, Mautner VF, Kurtz A, Park SJ, Baier M, Harder A, Reuss D, von Deimling A, Heppner FL, Holtkamp N.	PLoS One	2012
Systemic inflammation, intraventricular hemorrhage, and white matter injury. Leviton A, Allred EN, Dammann O, Engelke S, Fichorova RN, Hirtz D, Kuban KC, Ment LR, O'shea TM, Paneth N, Shah B, Schreiber MD.	J Child Neurol.	2012
A Potent Anti-HB-EGF Monoclonal Antibody Inhibits Cancer Cell Proliferation and Multiple Angiogenic Activities of HB-EGF. Sato S, Drake AW, Tsuji I, Fan J.	PLoS One	2012
Experimental pain and opioid analgesia in volunteers at high risk for obstructive sleep apnea Doufas AG, Tian L, Padrez KA, Suwanprathes P, Cardell JA, Maecker HT, Panousis P.	PLoS One	2013
Phase I study of Dovitinib (TKI258), an oral FGFR, VEGFR, and PDGFR inhibitor, in advanced or metastatic renal cell carcinoma. Angevin E, Lopez-Martin JA, Lin CC, Gschwend JE, Harzstark A, Castellano D, Soria JC, Sen P, Chang J, Shi M, Kay A, Escudier B.	Clin Cancer Res	2013
A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study. Hirata S, Dirven L, Shen Y, Centola M, Cavet G, Lems WF, Tanaka Y, Huizinga TW, Allaart CF.	Rheumatology (Oxford)	2013
Phase II study evaluating 2 dosing schedules of oral Foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric cancer. Shah MA, Wainberg ZA, Catenacci DVT, Hochster HS, Ford J, Kunz P, Lee F, Kallender H, Cecchi F, Rabe DC, Keer H, Martin A, Liu Y, Gagnon R, Bonate P, Liu L, Gilmer T, Bottaro DP.	PLoS One	2013
Suppression of DHT-induced paracrine stimulation of endothelial cell growth by estrogens via prostate cancer cells. Wen J, Zhao Y, Li J, Weng C, Cai J, Yang K, Yuan H, Imperato-McGinley J, Zhu YS.	Prostate	2013